Comparison of interferon {gamma} release assays and conventional screening tests before tumour necrosis factor {alpha} blockade in patients with inflammatory arthritis.
about
A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor α inhibitorChoice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective.Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy.Immunosuppression Adversely Affects TST but Not IGRAs in Patients with Psoriasis or Inflammatory Musculoskeletal Diseases.Safety, pharmacokinetics, and biologic activity of pateclizumab, a novel monoclonal antibody targeting lymphotoxin α: results of a phase I randomized, placebo-controlled trial.Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the EvidenceIFN-γ release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults.Adverse effects of golimumab in the treatment of rheumatologic diseases.Screening of latent tuberculosis infection by interferon-γ release assays in rheumatic patients: a systemic review and meta-analysis.Performance of QuantiFERON(®)-TB Gold In-Tube assay in children receiving disease modifying anti-rheumatic drugs.Isoniazid treatment for latent tuberculosis infection is tolerable for rheumatoid arthritis patients receiving tumor necrosis factor inhibitor therapy.Three years of experience with QuantiFERON-TB gold testing in patients with uveitis.Negative effect of immunosuppressive therapy in the performance of the QuantiFERON gold in-tube test in patients with immune-mediated inflammatory diseases.Evaluation of screening methods for identification of patients with chronic rheumatological disease requiring tuberculosis chemoprophylaxis prior to commencement of TNF-α antagonist therapy.T-cell profiling and the immunodiagnosis of latent tuberculosis infection in patients with inflammatory bowel disease.Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infectionSerial interferon-γ release assays for screening and monitoring of tuberculosis infection during treatment with biologic agentsInterferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment
P2860
Q34709566-43123682-01F6-4C73-83F6-159F04939ACFQ35237588-5A50F48C-3715-4F17-BEC5-4C8770A1BD9BQ35598203-9E515F92-B30D-4D7C-BA26-F4DBDA2D2E42Q35993903-B33EE571-E66E-4F43-B09E-BDB13ECDF118Q36084891-1C8441BA-43D7-4AB8-BF77-A8DC0AA22C95Q36637982-26079D3D-9D88-49B8-B42A-A7E5C81074C0Q38069419-1D4F6780-A071-4B0F-9858-A5938594AD08Q38132273-BB55A9A8-DB8E-4DB8-B4D9-13A88EB3F44DQ38265740-C1F88201-CDBE-40BB-B35C-E6CD27CA4F73Q40159900-CFF18012-4D4B-4DCE-BF08-3E8EF3776993Q40296409-E984711B-5F9F-479A-AADB-C1731011909DQ42233490-B09339D5-2340-46AB-8A8C-5611BE39CD7EQ45095583-2502D903-B99F-49AA-B7E8-6340228912FEQ47119702-3426372C-6CA8-47A4-9D64-797E0C24ACDCQ53075558-D2236A36-83CE-4088-9DFD-73F97BC09FF7Q56974048-C3D1532E-47DD-4850-8677-DA07CD69B2C4Q58480211-6F204BA2-4543-4B30-AE7C-30CCD1F5ADF4Q58924832-F5E9CF9D-CB13-4736-98F8-825CEB67C78F
P2860
Comparison of interferon {gamma} release assays and conventional screening tests before tumour necrosis factor {alpha} blockade in patients with inflammatory arthritis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Comparison of interferon {gamm ...... s with inflammatory arthritis.
@ast
Comparison of interferon {gamm ...... s with inflammatory arthritis.
@en
type
label
Comparison of interferon {gamm ...... s with inflammatory arthritis.
@ast
Comparison of interferon {gamm ...... s with inflammatory arthritis.
@en
prefLabel
Comparison of interferon {gamm ...... s with inflammatory arthritis.
@ast
Comparison of interferon {gamm ...... s with inflammatory arthritis.
@en
P2093
P50
P356
P1476
Comparison of interferon {gamm ...... ts with inflammatory arthritis
@en
P2093
B Bresnihan
O Fitzgerald
T McDonnell
P304
P356
10.1136/ARD.2008.101857
P407
P577
2010-01-01T00:00:00Z